No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients

Schizophrenia Research

Volumn 101, Issue 1-3, 2008, Pages 50-57

  Bromberg, A ^a   Levine, J ^a   Nemetz, B ^a   Belmaker, R H ^a   Agam, G ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

DNA methylation; Homocysteine; Leukocyte; Schizophrenia

Indexed keywords

CYTOSINE; GENOMIC DNA; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA METHYLATION; FEMALE; GENOME; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; CYSTAMINE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; SCHIZOPHRENIA; SEX FACTORS;

EID: 43049104493     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.01.009     Document Type: Article

References (57)

1. Applebaum J., Shimon H., Sela B.A., Belmaker R.H., and Levine J. Homocysteine levels in newly admitted schizophrenic patients. J. Psychiatr. Res. 38 (2004) 413-416
2. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422 (1987) 43-52
3. Bazire. Psychotropic Drug Directory (2003), Quay Books, Salisbury
4. Bird A.P., and Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 99 (1999) 451-454
5. Bleich S., Frieling H., and Hillemacher T. Elevated prenatal homocysteine levels and the risk of schizophrenia. Arch. Gen. Psychiatry 64 (2007) 980-981
6. Bonsch D., Lenz B., Reulbach U., Kornhuber J., and Bleich S. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J. Neural Transm. 111 (2004) 1611-1616
7. Brown A.S., Bottiglieri T., Schaefer C.A., Quesenberry Jr. C.P., Liu L., Bresnahan M., and Susser E.S. Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch. Gen. Psychiatry 64 (2007) 31-39
8. Cannon M., Jones P.B., and Murray R.M. Obstetric complications and schizophrenia: historical and meta-analytic review. Am. J. Psychiatry 159 (2002) 1080-1092
9. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., Blom H.J., Jakobs C., and Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49 (2003) 1292-1296
10. Caudill M.A., Wang J.C., Melnyk S., Pogribny I.P., Jernigan S., Collins M.D., Santos-Guzman J., Swendseid M.E., Cogger E.A., and James S.J. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 131 (2001) 2811-2818
11. Chen T., Ueda Y., Dodge J.E., Wang Z., and Li E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23 (2003) 5594-5605
12. Choi S.W., Friso S., Dolnikowski G.G., Bagley P.J., Edmondson A.N., Smith D.E., and Mason J.B. Biochemical and molecular aberrations in the rat colon due to folate depletion are age-specific. J. Nutr. 133 (2003) 1206-1212
13. Cohen S.M., Nichols A., Wyatt R., and Pollin W. The administration of methionine to chronic schizophrenic patients: a review of ten studies. Biol. Psychiatry. 8 (1974) 209-225
14. Davis C.D., and Uthus E.O. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J. Nutr. 133 (2003) 2907-2914
15. Friso S., Lamon-Fava S., Jang H., Schaefer E.J., Corrocher R., and Choi S.W. Oestrogen replacement therapy reduces total plasma homocysteine and enhances genomic DNA methylation in postmenopausal women. Br. J. Nutr. 97 (2007) 617-621
16. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
17. Fux R., Kloor D., Hermes M., Rock T., Proksch B., Grenz A., Delabar U., Bucheler R., Igel S., Morike K., Gleiter C.H., and Osswald H. Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. Am. J. Physiol., Renal. Physiol. 289 (2005) F786-F792
18. Glantz L.A., Gilmore J.H., Lieberman J.A., and Jarskog L.F. Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr. Res. 81 (2006) 47-63
19. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., and Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9341-9346
20. Graziano F., Kawakami K., Ruzzo A., Watanabe G., Santini D., Pizzagalli F., Bisonni R., Mari D., Floriani I., Catalano V., Silva R., Tonini G., Torri V., Giustini L., and Magnani M. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int. J. Cancer 118 (2006) 628-632
21. Hoffman D.R., Marion D.W., Cornatzer W.E., and Duerre J.A. S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of l-methionine, l-homocystein, and adenosine. J. Biol. Chem. 255 (1980) 10822-10827
22. James S.J., Melnyk S., Pogribna M., Pogribny I.P., and Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 132 (2002) 2361S-2366S
23. Jones P.A., and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293 (2001) 1068-1070
24. Joober R., Benkelfat C., Lal S., Bloom D., Labelle A., Lalonde P., Turecki G., Rozen R., and Rouleau G.A. Association between the methylenetetrahydrofolate reductase 677C->T missense mutation and schizophrenia. Mol. Psychiatry 5 (2000) 323-326
25. Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., and Iacopetta B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br. J. Cancer 94 (2006) 593-598
26. Kruman II, Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., and Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20 (2000) 6920-6926
27. Lau C.G., and Zukin R.S. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat. Rev. Neurosci. 8 (2007) 413-426
28. Lentz S.R. Mechanisms of homocysteine-induced atherothrombosis. J. Thromb. Haemost. 3 (2005) 1646-1654
29. Levine J., Stahl Z., Sela B.A., Gavendo S., Ruderman V., and Belmaker R.H. Elevated homocysteine levels in young male patients with schizophrenia. Am. J. Psychiatry 159 (2002) 1790-1792
30. Lewis S.J., Zammit S., Gunnell D., and Smith G.D. A meta-analysis of the MTHFR C677T polymorphism and schizophrenia risk. Am. J. Med. Genet., B, Neuropsychiatr. Genet. 135 (2005) 2-4
31. Lin R.K., Hsu H.S., Chang J.W., Chen C.Y., Chen J.T., and Wang Y.C. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 55 (2007) 205-213
32. Lipton S.A., Kim W.K., Choi Y.B., Kumar S., D'Emilia D.M., Rayudu P.V., Arnelle D.R., and Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 5923-5928
33. Lund G., Andersson L., Lauria M., Lindholm M., Fraga M.F., Villar-Garea A., Ballestar E., Esteller M., and Zaina S. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J. Biol. Chem. 279 (2004) 29147-29154
34. Matsubayashi H., Skinner H.G., Iacobuzio-Donahue C., Abe T., Sato N., Riall T.S., Yeo C.J., Kern S.E., and Goggins M. Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin. Gastroenterol. Hepatol. 3 (2005) 752-760
35. Mill J., and Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 12 (2007) 799-814
36. Muntjewerff J.W., Kahn R.S., Blom H.J., and den Heijer M. Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis. Mol. Psychiatry 11 (2006) 143-149
37. Murray R.M. Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. Br. J. Psychiatry. (1994) 6-12 Suppl
38. Nevo G.A., Meged S., Sela B.A., Hanoch-Levi A., Hershko R., and Weizman A. Homocysteine levels in adolescent schizophrenia patients. Eur. Neuropsychopharmacol. 16 (2006) 588-591
39. Nygard O., Refsum H., Ueland P.M., and Vollset S.E. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland homocysteine study. Am. J. Clin. Nutr. 67 (1998) 263-270
40. Piyathilake C.J., Frost A.R., Bell W.C., Oelschlager D., Weiss H., Johanning G.L., Niveleau A., Heimburger D.C., and Grizzle W.E. Altered global methylation of DNA: an epigenetic difference in susceptibility for lung cancer is associated with its progression. Hum. Pathol. 32 (2001) 856-862
41. Pogribny I., Yi P., and James S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262 (1999) 624-628
42. Rampersaud G.C., Kauwell G.P., Hutson A.D., Cerda J.J., and Bailey L.B. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr. 72 (2000) 998-1003
43. Refsum H., Nurk E., Smith A.D., Ueland P.M., Gjesdal C.G., Bjelland I., Tverdal A., Tell G.S., Nygard O., and Vollset S.E. The Hordaland homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J. Nutr. 136 (2006) 1731S-1740S
44. Regland B., Johansson B.V., Grenfeldt B., Hjelmgren L.T., and Medhus M. Homocysteinemia is a common feature of schizophrenia. J. Neural. Transm., Gen. Sect. 100 (1995) 165-169
45. Regland B., Germgard T., Gottfries C.G., Grenfeldt B., and Koch-Schmidt A.C. Homozygous thermolabile methylenetetrahydrofolate reductase in schizophrenia-like psychosis. J. Neural. Transm. 104 (1997) 931-941
46. Robertson K.D., and Wolffe A.P. DNA methylation in health and disease. Nat. Rev. Genet. 1 (2000) 11-19
47. Sachdev P.S., Valenzuela M., Wang X.L., Looi J.C., and Brodaty H. Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals. Neurology 58 (2002) 1539-1541
48. Sazci A., Ergul E., Guzelhan Y., Kaya G., and Kara I. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res. Mol. Brain Res. 117 (2003) 104-107
49. Shimabukuro M., Jinno Y., Fuke C., and Okazaki Y. Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav. Brain Funct. 2 (2006) 37
50. Shimabukuro M., Sasaki T., Imamura A., Tsujita T., Fuke C., Umekage T., Tochigi M., Hiramatsu K., Miyazaki T., Oda T., Sugimoto J., Jinno Y., and Okazaki Y. Global hypomethylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. J. Psychiatr. Res. 41 (2007) 1042-1046
51. Smith I.M., Mydlarz W.K., Mithani S.K., and Califano J.A. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int. J. Cancer 121 (2007) 1724-1728
52. Soma T., Kaganoi J., Kawabe A., Kondo K., Imamura M., and Shimada Y. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells. Int. J. Cancer 119 (2006) 1023-1027
53. Ting Hsiung D., Marsit C.J., Houseman E.A., Eddy K., Furniss C.S., McClean M.D., and Kelsey K.T. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol. Biomark. Prev. 16 (2007) 108-114
54. Veldic M., Guidotti A., Maloku E., Davis J.M., and Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2152-2157
55. Woods. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 64 (2003) 663-667
56. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275 (2000) 29318-29323
57. Yokomori N., Moore R., and Negishi M. Sexually dimorphic DNA demethylation in the promoter of the Slp (sex-limited protein) gene in mouse liver. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1302-1306